Edesa Biotech (EDSA) Tops Q1 EPS by 67c

Edesa Biotech (NASDAQ: EDSA) reported Q1 EPS of ($0.54), $0.67 better than the analyst estimate of ($1.21).

For earnings history and earnings-related data on Edesa Biotech (EDSA) click here.

You May Also Be Interested In

• AI chip winners may face tougher road ahead as hyperscalers catch up: JPM
• Lindsay (LNN) Tops Q3 EPS by 18c, Misses on Revenue
• Brookline Capital Markets Starts Edesa Biotech Inc. (EDSA) at Buy